{"id":"NCT04039503","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin","officialTitle":"Randomized, Phase 3, Double-blind Trial Comparing the Effect of the Addition of Tirzepatide Versus Placebo in Patients With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-08-30","primaryCompletion":"2020-12-22","completion":"2021-01-13","firstPosted":"2019-07-31","resultsPosted":"2022-01-12","lastUpdate":"2022-01-12"},"enrollment":475,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"Tirzepatide","otherNames":["LY3298176"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"5 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"10 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"15 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to compare the safety and efficacy of the study drug tirzepatide to placebo in participants with type 2 diabetes that are already on insulin glargine, with or without metformin. Participants will administer tirzepatide or placebo along with their previous glucose lowering medications. The study will last approximately 47 weeks and may include about 23 visits.","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin A1c (HbA1c) (10 mg and 15 mg)","timeFrame":"Baseline, Week 40","effectByArm":[{"arm":"10 mg Tirzepatide","deltaMin":-2.59,"sd":0.081},{"arm":"15 mg Tirzepatide","deltaMin":-2.59,"sd":0.083},{"arm":"Placebo","deltaMin":-0.93,"sd":0.079}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":48,"countries":["United States","Czechia","Germany","Japan","Poland","Puerto Rico","Slovakia","Spain"]},"refs":{"pmids":["39531161","37668888","37526908","35210595","35133415"],"seeAlso":["https://trials.lillytrialguide.com/en-US/trial/33Mn9pqfndRwZEPVvpNxDR"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":116},"commonTop":["Diarrhoea","Nasopharyngitis","Nausea","Decreased appetite","Vomiting"]}}